Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011;12(9):5871-7.
doi: 10.3390/ijms12095871. Epub 2011 Sep 14.

Diagnostic performance of 1→3-β-d-glucan in neonatal and pediatric patients with Candidemia

Maria Teresa Montagna  1 , Caterina Coretti, Grazia Lovero, Osvalda De Giglio, Osvaldo Montagna, Nicola Laforgia, Nicola Santoro, Giuseppina Caggiano
Affiliations

Diagnostic performance of 1→3-β-d-glucan in neonatal and pediatric patients with Candidemia

Maria Teresa Montagna et al. Int J Mol Sci. 2011.

Abstract

Fungal sepsis is one of the major problems in neonatal and pediatric care unit settings. The availability of new diagnostic techniques could allow medical practitioners to rapidly identify septic patients and to improve their outcome. The aim of this study was to evaluate the performance of the 1→3-β-d-glucan (BDG), individually and in comparison with the Candida mannan (CM) antigen, in ten preterm infants and five onco-haematological pediatric patients with Candida bloodstream infections already proven by positive culture. The serum levels of BDG were >80 pg/mL on the same day as a positive blood culture in all examined patients, while CM antigen was negative in the patients with C. parapsilosis fungemia and in one further case due to C. albicans. These results suggest that a regular monitoring of serum circulating antigens (i.e., 1→3-β-d-glucan) combined with other microbiological and clinical information, may allow earlier and accurate diagnosis. However, further studies are necessary to confirm its usefulness in routine clinical practice.

Keywords: 1→3-β-d-glucan; candidemia; mannan antigen; pediatric patients.

PubMed Disclaimer

References

    1. Montagna MT, Caggiano G, Borghi E, Morace G. The role of the laboratory in the diagnosis of invasive candidiasis. Drugs. 2009;69:59–63. - PubMed
    1. Posteraro B, Torelli R, De Carolis E, Posteraro P, Sanguinetti M. Update on the laboratory diagnosis of invasive fungal infections. Mediterr J Hematol Infect Dis. 2011:e2011002. doi: 10.4084/MJHID.2011.002. - DOI - PMC - PubMed
    1. Ellepola AN, Morrison CJ. Laboratory diagnosis of invasive candidiasis. J Microbiol. 2005;43:65–84. - PubMed
    1. Oliveri S, Trovato L, Betta P, Romeo MG, Nicoletti G. Experience with the Platelia Candida ELISA for the diagnosis of invasive candidosis in neonatal patients. Clin Microbiol Infect. 2008;14:391–393. - PubMed
    1. Ostrosky-Zeichner L, Alexander BD, Kett DH, Vazquez J, Pappas PG, Saeki F, Ketchum PA, Wingard J, Schiff R, Tamura H, et al. Multicenter clinical evaluation of the (1→3) β-d-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis. 2005;41:654–659. - PubMed

Publication types

LinkOut - more resources